Key facts
- This page summarizes Mala Murthy's Form 4 filing for Teladoc Health, Inc. (TDOC).
- 16 reported transactions and 8 derivative rows are listed below.
- Accepted by SEC: 05 Mar 2024, 16:07.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Additional SEC filing notes
Footnote F1
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Footnote F2
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Footnote F3
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
Footnote F4
Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
Footnote F5
Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
Footnote F6
The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Footnote F7
On March 1, 2024, the reporting person earned 31,696 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Footnote F8
On March 2, 2023, the reporting person earned 1,893 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
Footnote F9
On March 2, 2022, the reporting person earned 5,637 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
Footnote F10
On March 1, 2022, the reporting person was granted 40,426 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Footnote F11
On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Footnote F12
On March 3, 2023, the reporting person was granted 93,006 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Footnote F13
On March 2, 2021, the reporting person was granted 7,457 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.